The Food and Drug Administration (FDA) has approved Enhertu (fam-trastuzumab-deruxtecan-nxki), a HER2-directed antibody and topoisomerase inhibitor conjugate, for the treatment...
Read moreBioNTech expects to begin deliveries of two Omicron-adapted vaccines as soon as October. The German biotech firm, which makes the...
Read moreThe Food and Drug Administration (FDA) has approved Nubeqa® (darolutamide), an androgen receptor inhibitor, in combination with docetaxel for the...
Read morePeople who are severely ill with myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) are often too sick to leave home, but clinicians...
Read moreThere’s really no ignoring the inexorable math that led the Senate to approve a plan that will give Medicare unprecedented...
Read moreIn a setback to GSK, a California judge ruled that a consumer cleared a key legal hurdle and can proceed...
Read moreCanadian singer Celine Dion’s diagnosis of Stiff Person Syndrome (SPS) in early December last year has stimulated thought-provoking discussions and...
Read moreLong COVID conditions can linger for weeks and even for months. The common symptoms of the condition are brain fog,...
Read more
© 2022 Medical News Hubb All rights reserved.
Use of these names, logos, and brands does not imply endorsement unless specified. By using this site, you agree to the Privacy Policy and Terms & Conditions.
